Why does drug resistance easily evolve but vaccine resistance does not?

Very good question and a very good answers in this article!

I'll add one more reason not explored by the authors: antibodies don't "leak" in the environment, in contrast to the antibiotics which are everywhere.

For example, if I'm vaccinated against S. pneumoniae (one of the bacteria that can cause pneumonia), the bacteria have to get inside my body to gain exposure to my vaccine-induced antibodies. This makes the emergence of resistance very unlikely because :

(1) the number of bacteria that are exposed to the antibody is relatively small, because the antibody response is pretty fast and happens before the bacteria had a chance to multiply to significant numbers; (2) any bacteria clones who evolve resistance to the antibody remain susceptible to the myriad of other immunes peptides, to macrophages, and so on. In other words, as long as I survive my pneumonia, no resistance can ever emerge, because I will kill all the resistant clones through other means.

Contrast this to antibiotics. I have pneumonia, I take antibiotics, I'm cured. However, I excrete those antibiotics in urine and stool. Outside of my body, enormous numbers of bacteria are exposed to minute doses of antibiotics. The number of surviving clones is likely to be very high, and those survivors do not face any supplemental threat. Thus, resistance to that antibiotic can be transmitted to later generations.

I like to use a conflict analogy: A drug is a weapon exploiting one weakness of the enemy. A vaccine is a visual identification of the enemy, passed on to special forces (your immune system). A single weakness can often be changed easily, but it's harder to shake off special forces.

"Here we argue that vaccines are less vulnerable to pathogen evolution than are antimicrobial drugs because of differences in the way drugs and vaccines work. We contend that two key features of vaccines have large, synergistic effects on the rate at which resistance arises and then spreads"

"(a) Timing of action - For most infectious diseases, hours to days elapse between exposure to a pathogen and symptomatic infection in a host ... Pathogen replication during this incubation period creates opportunities for mutations to arise"

"(b) Multiplicity of therapeutic targets within and between hosts - The benefit of combination therapy is based on the premise that resistance can only be acquired by the simultaneous acquisition of resistance to each component drug. The probability of simultaneous acquisition becomes vanishingly small as the number of drugs increases. A vaccine, however, often exposes the host immune system to multiple pathogen proteins (antigens), and multiple potential binding sites (epitopes) on each antigen. Epitopes are recognized and bound by components of the immune system analogously to how biochemical molecules would interact with a drug or its downstream products. This means that immunity is in effect acting like combination therapy, but with substantially more component effectors (and hence targets) than any drug cocktail."

------

"One set of differences between vaccines and drugs stem from the fact that vaccine effects are mediated through host immune responses while drugs effects are mediated through chemical pathways"

They discount this as being a major factor but the only evidence they provide is that "resistance is seen against drugs such as solfonamides that also act indirectly."

It could also be considered that the immune system is adaptive and its capacities evolve during a person's lifetime and that the collective immune system within a population group evolves depending on the spread (or lack there of) of disease within the population group.

With vaccines we are triggering the evolution of individual and group immune systems in ways that we don't fully understand and so unlike with drugs where once resistance is formed we have to develop a new drug, individual and group immune systems continue to evolve even if the vaccines don't change. The same vaccine administered now may be triggering different responses than it did 100 years ago.

While I do not doubt that this difference exists in general, I am wondering if there is not, to some extent, an issue of terminology here. My understanding is that influenza vaccination is somewhat uncertain because antigenic shift and drift produces new, or not-recently-seen, strains. When a bacterium modifies its genome to survive an antimicrobial drug, we call that 'resistance', yet I guess the drug is still as effective as before against unmodified bacteria. While the mechanism is, in detail, different in the two cases, they both involve the pathogen modifying its genome to render the treatment less effective.

Maybe the distinction is because, in the case of influenza, the strain changes are not in response to, and driven by, the treatment? HIV, however, seems to be very effective in mutating specifically in response to every candidate vaccine that has been tried against it.

I always figured it was because there were thousands of different types of antibodies generated against an immunological challenge (e.g. vaccine).

The antibody simply finds a conserved binding site and it works. Therefore, they don't have to be the same.

As a result, resistance doesn't form as the bacteria or virus would need to develop resistance to thousands of different antibodies, not just one.

Not a biologist here, but hoping maybe one can correct me on this: isn't it an important factor that in the immune system the signaling cells themselves have evolved to respond to variants of a given pathogen's protein marker, whereas drugs are always presenting the same chemical challenge?

My understanding is that we're unable to created effective vaccines against RNA viruses as RNA replication doesn't have the built-in "checksum" mechanism that DNA has. When DNA replicates, because the two strands of the helix are essentially mirror images of each other, it is easier to create an exact copy without mutations. RNA, not having this property, allows for more mutations during replication. This increased mutation rate is what causes the viruses to change so quickly and what makes the vaccines we create quickly useless against the changed virus.

The decreasing effectiveness of the flu vaccine suggests to me that the flu metagenome is evolving resistance to our vaccine generation strategy.

Don't bacteria have a way of swapping genes that was discovered recently?